Jefferies Lowers Numbers on Caribou Coffee (CBOU), Keeps Buy
Tweet Send to a FriendGet Alerts CBOU Hot Sheet
Price: $15.99 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Trade CBOU Now!
Jefferies lowered estimates and its price target on Caribou Coffee (NASDAQ: CBOU) from $22 to $16 following solid Q2 results, but weak K-cup sales and lower guidance. However, the firm maintained their Buy rating.
"Stock weak on K-Cup visibility, but we think issues are transitory (only ~15% of op profits) & see 25%+ EPS gr. in '13 on coffee tailwinds/solid fundamentals in rest of biz," the analyst comments.
FY12 EPS goes from $0.49 to $0.45 and FY13 from $0.70 to $0.60.
For an analyst ratings summary and ratings history on Caribou Coffee click here. For more ratings news on Caribou Coffee click here.
Shares of Caribou Coffee closed at $10.95 yesterday, with a 52 week range of $9.93-$18.84.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
"Stock weak on K-Cup visibility, but we think issues are transitory (only ~15% of op profits) & see 25%+ EPS gr. in '13 on coffee tailwinds/solid fundamentals in rest of biz," the analyst comments.
FY12 EPS goes from $0.49 to $0.45 and FY13 from $0.70 to $0.60.
For an analyst ratings summary and ratings history on Caribou Coffee click here. For more ratings news on Caribou Coffee click here.
Shares of Caribou Coffee closed at $10.95 yesterday, with a 52 week range of $9.93-$18.84.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Wells Fargo Downgrades Ruby Tuesday (RT) to Market Perform
- Goldman Sachs Upgrades Abbott Labs (ABT) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

